Michael Osborne
About Michael Osborne
Michael Osborne serves as the Vice President and Head of Business Development at Andelyn Biosciences, where he has worked since 2020. He possesses over 20 years of leadership experience in various sectors, with a focus on the commercialization of orphan drugs and rare diseases.
Work at Andelyn Biosciences
Michael Osborne serves as the Vice President and Head of Business Development at Andelyn Biosciences since 2020. In this role, he focuses on the commercialization of orphan drugs, particularly those targeting rare diseases. He has played a significant role in the development of Zolgensma, the first commercial in vivo gene therapy for spinal muscular atrophy. His leadership at Andelyn Biosciences emphasizes strategic growth and innovation within the biotech sector.
Education and Expertise
Michael Osborne holds a Master of Business Administration (MBA) from Providence College, where he studied from 2001 to 2002. He also earned a Bachelor of Science (B.S.) in Marketing from the same institution, completing his studies from 1997 to 2001. His educational background supports his expertise in the commercialization of orphan drugs, guiding projects from concept through to current Good Manufacturing Practice (cGMP) compliance.
Background
Michael Osborne has over 20 years of leadership experience across various sectors, including biotech Contract Development and Manufacturing Organizations (CDMO), pharmaceuticals, medical devices, healthcare finance, and animal health. His diverse background equips him with a comprehensive understanding of the industry, enhancing his effectiveness in business development roles.
Previous Experience
Before joining Andelyn Biosciences, Michael Osborne worked at Boston Institute of Biotechnology, LLC as VP/Director of Business Development from 2017 to 2018. He also served as a CDMO Consultant at the same organization from 2018 to 2020. His earlier roles include Regional Director at Trupanion from 2012 to 2016 and Practice Development Manager at GE Capital - CareCredit from 2007 to 2012. These positions contributed to his extensive knowledge and skills in business development and market strategy.